Development

Patricia Van Arnum was executive editor of Pharmaceutical Technology.

Articles

Developing and implementing true collaboration in customer/supplier relationships. This article is part of a special section on sourcing and corporate social responsibility.

Seeking Idealized Design to Collaborative Innovation in Sourcing and Procurement

Genzyme Sells Business Unit to Sekisui Chemical; Ablexis Names VP of Research; and More.

Week of Nov. 22, 2010: Company and People Notes: Genzyme Sells Business Unit to Sekisui Chemical; Ablexis Names VP of Research; and More.

During the 20 months before the crisis of contaminated heparin in early 2008, the US Food and Drug Administration did not inspect any Chinese heparin firms, according to a US Government Accountability Office, (GAO) report.

GAO Evaluates FDA's Response to 2008 Heparin Crisis

Roche Details Restructuring Plan; Sigma-Aldrich Names Successors after CEO's Death; and More.

Week of Nov. 15, 2010: Company and People Notes: Roche Details Restructuring Plan; Sigma-Aldrich Names Successors after CEO's Death; and More.

Eli Lilly Acquires Avid Radiopharmaceuticals; EMA Recruiting New Director; and More

Week of Nov. 8, 2010: Company and People Notes: Eli Lilly Acquires Avid Radiopharmaceuticals; EMA Recruiting New Director; and More.

sanofi acquires BMP Sunstone; DCAT Names President; and More.

Week of Nov. 1, 2010: Company and People Notes: sanofi acquires BMP Sunstone; DCAT Names President; and More.

Abuse-deterrent combination drugs represent a niche area in formulation development.

Formulation Development Forum: Abuse-deterrent combination drugs

USP is working to ensure quality standards and to increase public information.

Inside USP: Adulteration and Contamination Awareness

IP rights and levels of innovation have opened a bit of controversy regarding decisions being made by Indian courts and legislators.

Report from India

Industrial and academic partnerships forge new territory in solid-state chemistry.

Ingredients